NasdaqCM - Nasdaq Real Time Price USD

Titan Pharmaceuticals, Inc. (TTNP)

3.7000

-0.1400

(-3.65%)

As of 2:06:03 PM EDT. Market Open.

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Name	Title	Pay	Exercised	Year Born
Mr. Weei Jye Chay	Chief Executive Officer	--	--	1973
Mr. Brynner Chiam	Acting Principal Financial Officer & Director	54.38k	--	1978
Jennifer Kiernan	Executive Assistant to CEO & Investor Communications Coordinator	--	--	--
Joe Schrei	Executive Director of Commercial Operations	--	--	--

10 East 53rd St.

Suite 3001

New York, NY 10022

United States

650 244 4990 https://www.titanpharm.com

Sector:: Healthcare
Industry:

Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.

Titan Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

May 13, 2025 at 8:00 PM UTC - May 19, 2025 at 8:00 PM UTC

Titan Pharmaceuticals, Inc. Earnings Date

April 22, 2025 at 12:00 AM UTC